192 related articles for article (PubMed ID: 36553636)
21. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
22. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
23. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
24. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
Forghanifard MM; Kasebi P; Abbaszadegan MR
Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
[TBL] [Abstract][Full Text] [Related]
25. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
Wu KJ; Yang MH
Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
[TBL] [Abstract][Full Text] [Related]
27. NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.
Deng L; Zhang X; Xiang X; Xiong R; Xiao D; Chen Z; Liu K; Feng G
Technol Cancer Res Treat; 2021; 20():15330338211038492. PubMed ID: 34520294
[No Abstract] [Full Text] [Related]
28. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
[TBL] [Abstract][Full Text] [Related]
29. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
30. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
[TBL] [Abstract][Full Text] [Related]
31. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
32. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
33. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
Wu KJ
Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
[TBL] [Abstract][Full Text] [Related]
34. HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain stemness properties through increased Twist1 stability.
Yu CY; Liu BH; Tang SY; Liang RY; Hsu KH; Chuang SM
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118537. PubMed ID: 31487504
[TBL] [Abstract][Full Text] [Related]
35. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
36. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
Dai SL; Wei SS; Zhang C; Li XY; Liu YP; Ma M; Lv HL; Zhang Z; Zhao LM; Shan BE
Cancer Sci; 2021 Mar; 112(3):1060-1074. PubMed ID: 33340431
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients.
Moghbeli M; Forghanifard MM; Aarabi A; Mansourian A; Abbaszadegan MR
Pathol Oncol Res; 2014 Apr; 20(2):427-33. PubMed ID: 24163304
[TBL] [Abstract][Full Text] [Related]
38. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
39. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
40. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
